» Articles » PMID: 33586463

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease

Overview
Date 2021 Feb 15
PMID 33586463
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac fibroblasts are the primary cell type responsible for deposition of extracellular matrix in the heart, providing support to the contracting myocardium and contributing to a myriad of physiological signaling processes. Despite the importance of fibrosis in processes of wound healing, excessive fibroblast proliferation and activation can lead to pathological remodeling, driving heart failure and the onset of arrhythmias. Our understanding of the mechanisms driving the cardiac fibroblast activation and proliferation is expanding, and evidence for their direct and indirect effects on cardiac myocyte function is accumulating. In this review, we focus on the importance of the fibroblast-to-myofibroblast transition and the cross talk of cardiac fibroblasts with cardiac myocytes. We also consider the current use of models used to explore these questions.

Citing Articles

Bioprinting approaches in cardiac tissue engineering to reproduce blood-pumping heart function.

Kim M, Hwang D, Jang J iScience. 2025; 28(1):111664.

PMID: 39868032 PMC: 11763539. DOI: 10.1016/j.isci.2024.111664.


Competitive signaling and cellular communications in myocardial infarction response.

Nair V, Demitri C, Thankam F Mol Biol Rep. 2025; 52(1):129.

PMID: 39820809 PMC: 11739196. DOI: 10.1007/s11033-025-10236-5.


Extracellular PKM2 Preserves Cardiomyocytes and Reduces Cardiac Fibrosis During Myocardial Infarction.

Huang Y, Li B, Gui Z, Gao E, Yuan Y, Yang J Int J Mol Sci. 2025; 25(24.

PMID: 39769010 PMC: 11675365. DOI: 10.3390/ijms252413246.


Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy.

Wang B, Morsink M, Kim S, Luo L, Zhang X, Soni R J Clin Invest. 2025; 135(1).

PMID: 39744939 PMC: 11684812. DOI: 10.1172/JCI181630.


Epigenetic regulation of mitochondrial fission and cardiac fibrosis via sFRP3 promoter methylation.

Jiang S, Zhou Z, Tu B, Song K, Lin L, Liu Z Cell Mol Life Sci. 2024; 81(1):483.

PMID: 39644393 PMC: 11625034. DOI: 10.1007/s00018-024-05516-5.


References
1.
Ackers-Johnson M, Li P, Holmes A, OBrien S, Pavlovic D, Foo R . A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. Circ Res. 2016; 119(8):909-20. PMC: 5965670. DOI: 10.1161/CIRCRESAHA.116.309202. View

2.
Camacho P, Fan H, Liu Z, He J . Small mammalian animal models of heart disease. Am J Cardiovasc Dis. 2016; 6(3):70-80. PMC: 5030387. View

3.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

4.
Talman V, Ruskoaho H . Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016; 365(3):563-81. PMC: 5010608. DOI: 10.1007/s00441-016-2431-9. View

5.
Azevedo P, Polegato B, Minicucci M, Paiva S, Zornoff L . Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2015; 106(1):62-9. PMC: 4728597. DOI: 10.5935/abc.20160005. View